No Detail Found!

Hepatotoxicity with antituberculosis drugs: the risk factors.

Author(s)
Khalid Mahmood Department of Medicine, Med. Unit-V Dow Medical College & Civil Hospital, Karachi, Pakistan
Akhtar Hussain Department of Medicine, Med. Unit-V Dow Medical College & Civil Hospital, Karachi, Pakistan
Krishan Lal Jairamani Department of Medicine, Med. Unit-V Dow Medical College & Civil Hospital, Karachi, Pakistan
Abu-Talib Department of Medicine, Med. Unit-V Dow Medical College & Civil Hospital, Karachi, Pakistan
Badar-Uddin Abbasi Department of Medicine, Med. Unit-V Dow Medical College & Civil Hospital, Karachi, Pakistan
S. Salkeen Department of Medicine, Med. Unit-V Dow Medical College & Civil Hospital, Karachi, Pakistan
Abstract
To assess the severity and frequency of hepatotoxicity caused by different antituberculosis (AU) drugs and to evaluate whether concurrence of risk factors influence the antituberculosis drug induced hepatotoxicity. Method: This prospective cohort study was conducted in Medical Unit-V and OPD department of Civil Hospital Karachi from July 2004 to July 2005. A total of 339 patients diagnosed of active tuberculosis infection with normal pretreatment liver function were monitored clinically as well as biochemically. Their data were collected on proforma and patients were treated with Isonized, Rifampicin and Pyrazinamide. Duration after which derangement in function, if any, occurred and time taken for normalization was noted. Treatment was altered as needed, with exclusion of culprit drug. Finally data was analyzed by SPSS version 10.0. Results: AU induced hepatotoxicity was seen in 67 (19.76%) out of 339 patients. Females were more affected as compared to males (26.3% vs. 19.7%). BMI (kg/m2) of 91% of diseased group were less than 18.5 (p
Publication Details
Page(s) 33-38
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 23, Issue: 1, Year: 2007

Request the full text from PASTIC

0

Citations

0

Downloads

82

Views